Showing results (2061-2070 of 3,796) with videos related to

Sort By:
Pageof 380
Oncoimmunology|December 10, 2020
Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort StudiesZhenyu Huo, Caichen Li, Xin Xu, et al.
Oncoimmunology|December 10, 2020
Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibitionHans Urban, Laurent M Willems, Michael W Ronellenfitsch, et al.
Oncoimmunology|December 10, 2020
Quantitative MRI cell tracking of immune cell recruitment to tumors and draining lymph nodes in response to anti-PD-1 and a DPX-based immunotherapyMarie-Laurence Tremblay, Zoe O'Brien-Moran, James A Rioux, et al.
Oncoimmunology|December 15, 2018
Identification and editing of stem-like cells in methylcholanthrene-induced sarcomasEmilie T E Gross, Carlos D Peinado, Yujin Jung, et al.
Oncoimmunology|December 15, 2018
BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathwaysPeng Yue, Taylor Harper, Silvia M Bacot, et al.
Oncoimmunology|December 15, 2018
Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningiomaDustin T Proctor, Zeel Patel, Sanju Lama, et al.
Oncoimmunology|December 15, 2018
The role of CMV in glioblastoma and implications for immunotherapeutic strategiesMaryam Rahman, Farhad Dastmalchi, Aida Karachi, et al.
Oncoimmunology|December 15, 2018
lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progressionMingyan Huang, Huamin Wang, Xiang Hu, et al.
Oncoimmunology|December 15, 2018
TGF-β enhances the cytotoxic activity of Vδ2 T cellsChristian Peters, Annika Meyer, Léonce Kouakanou, et al.
Oncoimmunology|December 15, 2018
Therapeutic vaccination using minimal HPV16 epitopes in a novel MHC-humanized murine HPV tumor modelSebastian Kruse, Marleen Büchler, Philipp Uhl, et al.
Pageof 380